title: How academic labs can approach the drug discovery process as a way to synergize with big pharma.
abstract: While the pharmaceutical industry is facing highly challenging times, the academic drug discovery sector has the potential to contribute meaningfully to the discovery of novel drug targets and to the development of new mode-of-action therapeutics against a range of diseases, including rare and neglected diseases.
authors.affiliation: Department of Molecular Medicine, University of Padua, Padua, Italy. arianna.loregian@unipd.it
authors.forename: Arianna
authors.initials: A
authors.lastname: Loregian
authors.forename: Giorgio
authors.initials: G
authors.lastname: Palù
mesh_terms: D000046:Academic Medical Centers / Q000458:organization & administration*; D035843:Biomedical Research; D055808:Drug Discovery; D004345:Drug Industry / Q000458:organization & administration*; D006801:Humans; D055818:Public-Private Sector Partnerships; D014495:Universities / Q000458:organization & administration*